Ribbon cutting ceremony highlights commitment to animal health and local community investment
Pegasus Laboratories, a subsidiary of PBI-Gordon Companies and a leading manufacturer of veterinary pharmaceuticals, is hosting a ribbon cutting ceremony to celebrate the grand opening of its expanded facility in Pensacola. The event takes place today, September 18, 2025, at 10:00 a.m. at the newly renovated facility in the Ellyson Industrial Park.
This expansion is a critical step in Pegasus Laboratories’ continued growth and commitment to improving animal health across the nation. The new facility, spanning 172,000 square feet, consist of a three phased build out which will increase manufacturing capacity, provide state-of-the-art laboratory spaces, and enhance the company’s ability to produce high-quality veterinary products for pets.
The expansion was made possible through the efforts of the FloridaWest Economic Development Alliance identifying a $2.5 million grant from Triumph Gulf Coast to the Pensacola–Escambia Promotion and Development Commission (PEDC) for the acquisition of the facility. FloridaWest served as the local economic development partner helping to advance the project, while Triumph Gulf Coast’s investment is part of its broader initiative to stimulate economic growth in the region through support for projects that create high-paying jobs and foster innovation.
“The funding of this renovated facility is an example of how targeted public investment can drive meaningful economic impact,” said David Bear, President of the FloridaWest board of directors. “We are thrilled to see Pegasus Laboratories continue to grow in Pensacola, creating valuable, high-skilled jobs in the life sciences sector.”
Pegasus Laboratories is advancing its expansion with the creation of nearly 70 new jobs, including highly skilled positions across manufacturing, quality control, research and development, and management. To date, the company has invested more than $7 million in capital expenditures toward the project, with additional build-out phases anticipated to require up to $45 million to bring the full development to completion.
“By expanding our operations in Pensacola, we’re not just increasing our production capacity, but we’re also investing in the future of our employees and the communities we serve,” said Steve Clifford, CEO of Pegasus Laboratories. “Our growth here is a direct result of the support from the FloridaWest Economic Development Alliance, Triumph Gulf Coast, and local economic development partners who understand the importance of sustainable, high-tech jobs.”
Pegasus Laboratories products are used by veterinarians across the country to treat a range of chronic conditions in pets. The new facility will enhance the company’s ability to meet growing demands for its high-quality products while adhering to the highest standards of manufacturing and animal health safety.
